Comparison of radioiodine-or radiobromine-labeled RGD peptides between direct and indirect labeling methods K Ogawa, T Takeda, M Yokokawa, J Yu, A Makino, Y Kiyono, K Shiba, ... Chemical and Pharmaceutical Bulletin 66 (6), 651-659, 2018 | 34 | 2018 |
Radiogallium complex-conjugated bifunctional peptides for detecting primary cancer and bone metastases simultaneously K Ogawa, J Yu, A Ishizaki, M Yokokawa, M Kitamura, Y Kitamura, K Shiba, ... Bioconjugate Chemistry 26 (8), 1561-1570, 2015 | 26 | 2015 |
Rationally designed peptide nanosponges for cell-based cancer therapy H Wang, AS Yapa, NL Kariyawasam, TB Shrestha, M Kalubowilage, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (8), 2555-2564, 2017 | 25 | 2017 |
Incorporating 131 I into a PAMAM (G5. 0) dendrimer-conjugate: design of a theranostic nanosensor for medullary thyroid carcinoma R He, H Wang, Y Su, C Chen, L Xie, L Chen, J Yu, Y Toledo, ... Rsc Advances 7 (26), 16181-16188, 2017 | 12 | 2017 |
Insights from Theory and Experiment on the Photochromic spiro-Dihydropyrrolo–Pyridazine/Betaine System A Fernando, TB Shrestha, Y Liu, AP Malalasekera, J Yu, EJ McLaurin, ... The Journal of Physical Chemistry A 120 (6), 875-883, 2016 | 12 | 2016 |
Peptide nanosponges designed for the delivery of perillyl alcohol to glioma cells AS Yapa, TB Shrestha, SO Wendel, M Kalubowilage, J Yu, H Wang, ... ACS Applied Bio Materials 2 (1), 49-60, 2018 | 10 | 2018 |
Peptide nanosponges designed for rapid uptake by leukocytes and neural stem cells AS Yapa, H Wang, SO Wendel, TB Shrestha, NL Kariyawasam, ... RSC advances 8 (29), 16052-16060, 2018 | 10 | 2018 |
Refined Insights in the Photochromic spiro-Dihydroindolizine/Betaine System A Fernando, AP Malalasekera, J Yu, TB Shrestha, EJ McLaurin, ... The Journal of Physical Chemistry A 119 (37), 9621-9629, 2015 | 10 | 2015 |
Anti-GD2 antibody for radiopharmaceutical imaging of osteosarcoma Y Fu, J Yu, I Liatsou, Y Du, A Josefsson, JR Nedrow, H Rindt, JN Bryan, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (13), 4382-4393, 2022 | 9 | 2022 |
Response of breast cancer carcinoma spheroids to combination therapy with radiation and DNA-PK inhibitor: growth arrest without a change in α/β ratio J Yu, R Lu, JR Nedrow, G Sgouros International journal of radiation biology 96 (12), 1534-1540, 2020 | 6 | 2020 |
Nano-inspired technologies for peptide delivery O Covarrubias-Zambrano, J Yu, SH Bossmann Current Protein and Peptide Science 21 (4), 379-400, 2020 | 6 | 2020 |
Synergy of iron chelators and therapeutic peptide sequences delivered via a magnetic nanocarrier GS Abayaweera, H Wang, TB Shrestha, J Yu, K Angle, P Thapa, ... Journal of Functional Biomaterials 8 (3), 23, 2017 | 6 | 2017 |
212Pb-conjugated anti-rat HER2/neu antibody against a neu-N derived murine mammary carcinoma cell line: cell kill and RBE in vitro I Liatsou, J Yu, R Bastiaannet, Z Li, RF Hobbs, J Torgue, G Sgouros International journal of radiation biology 98 (9), 1452-1461, 2022 | 5 | 2022 |
Bone marrow relative biological effectiveness for a 212Pb-labeled anti-HER2/neu antibody I Liatsou, A Josefsson, J Yu, A Cortez, R Bastiaannet, E Velarde, K Davis, ... International Journal of Radiation Oncology* Biology* Physics 115 (2), 518-528, 2023 | 3 | 2023 |
Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma—a proof of concept study I Liatsou, Y Fu, Z Li, M Hasan, X Guo, J Yu, J Piccolo, A Cartee, H Wang, ... European Journal of Nuclear Medicine and Molecular Imaging 51 (5), 1409-1420, 2024 | 2 | 2024 |
Evaluation of targeting αVβ3 in breast cancers using RGD peptide-based agents A Josefsson, AG Cortez, J Yu, S Majumdar, A Bhise, RF Hobbs, ... Nuclear Medicine and Biology 128, 108880, 2024 | 2 | 2024 |
Early Normal Tissue Effects and Bone Marrow Relative Biological Effectiveness for an Actinium 225-Labeled HER2/neu-Targeting Antibody I Liatsou, A Josefsson, J Yu, Z Li, K Davis, C Brayton, H Wang, RF Hobbs, ... International Journal of Radiation Oncology* Biology* Physics 117 (4), 1028-1037, 2023 | 2 | 2023 |
Structure determination, mode of action and safe delivery of an improved K6L9-type peptide TB Shrestha, J Yu, S Bossmann, D Troyer Cancer Research 78 (13_Supplement), 3730-3730, 2018 | 1 | 2018 |
Assembly of Mesoporous Silica Nanoparticle Drug Conjugates for Enhanced Delivery J Yu, L Chlebanowski, JL Hammer, P Thapa, TB Shrestha, H Wang, ... Supramolecular Nanotechnology: Advanced Design of Self‐Assembled Functional …, 2023 | | 2023 |
Bone marrow RBE for a 212Pb-conjugated anti-HER2/neu antibody I Liatsou, A Josefsson, J Yu, A Cortez, R Bastiaannet, E Velarde, ... Journal of Nuclear Medicine 63 (supplement 2), 4062-4062, 2022 | | 2022 |